International Journal of Applied Pharmaceutical Sciences (IJAPS) is a peer-reviewed, bimonthly open access journal committed to publishing high-quality original research that advances the field of pharmaceutical sciences.
Our mission is to serve as a global platform for researchers, academicians, and pharmaceutical professionals to share innovative findings that contribute meaningfully to scientific knowledge in pharmacy and related disciplines.
IJAPS employs a rigorous double-blind peer review process to ensure the integrity, quality, and significance of published research. We are committed to maintaining the highest ethical standards in academic publishing and adhere to international guidelines for publication ethics.
International Journal of Applied Pharmaceutical Sciences is an open access, peer-reviewed journal that aims to act as a platform for all areas of drug invention, design, manufacture, classification and assessment.
As an international journal, IJAPS considers outstanding studies from basic research to clinical investigations as Original Articles, Systematic Reviews, Meta-Analyses, General Reviews, Mini-Reviews, Short Communications and Editorials from the global scientific community.
The journal welcomes submissions from researchers, academicians and healthcare professionals across the world.
All articles published by International Journal of Applied Pharmaceutical Sciences are made freely and permanently accessible online immediately upon publication.
Authors retain copyright of their published work and grant readers the right to access, reproduce and distribute the content for academic and research purposes with proper citation.
International Journal of Applied Pharmaceutical Sciences operates a closed double-blind peer-review system.
Each submitted manuscript is evaluated by the Editors-in-Chief and assigned to qualified independent reviewers. Editorial decisions are based on reviewer recommendations, scientific quality, originality and relevance to the journal's scope.
Authors can monitor the status of their manuscript throughout the review process through communication with the editorial office.
Reports of original scientific investigations and experimental findings.
Comprehensive reviews summarizing recent developments and advances in specific areas of pharmaceutical research.
Brief reports presenting significant preliminary findings from original research.
Clinical observations that describe diagnostic challenges, therapeutic outcomes, unusual presentations or important adverse reactions.
Short opinion-based articles and critical analyses responding to published work or emerging issues.